Hormone therapy benefits and risks, by treatment goal

Start with the treatment goal

The clearest benefit is relief of vasomotor symptoms: hot flashes and night sweats.² Systemic therapy can also improve related sleep disruption for some patients. Low-dose local vaginal therapy is used for dryness, pain, and urinary symptoms when those are the main concern.

Hormone therapy can prevent bone loss and fractures while it is being used in appropriate patients. It is not prescribed simply to prevent aging, guarantee weight loss, or treat every nonspecific midlife symptom.

• Bothersome hot flashes and night sweats
• Vaginal and urinary symptoms
• Bone-loss prevention in selected patients
• Premature menopause or ovarian insufficiency under specialist guidance

Timing changes the balance

For most healthy, symptomatic patients younger than 60 or within 10 years of menopause onset, The Menopause Society says the benefit-risk balance is generally favorable.¹ Starting later or in the presence of certain health conditions can change that balance.

This is why a risk calculator or age cutoff cannot make the decision alone. Symptom burden, baseline risk, route, dose, and patient preference all matter.

Route, uterus, and formulation matter

Oral and transdermal estrogen have different effects on the body, and observational evidence suggests route can affect clotting risk.¹ Low-dose vaginal therapy has a different exposure profile from systemic treatment.

For a patient with a uterus, systemic estrogen is generally paired with a progestogen to protect against endometrial cancer.³ After hysterectomy, estrogen alone may be appropriate. FDA-approved products provide standardized labeling and manufacturing review; compounded products are not proven to be safer or more effective.

Review risks and follow the plan over time

Potential risks can include blood clots, stroke, gallbladder disease, and certain cancers³, with the absolute risk depending on the regimen and patient. A clinician should review unexplained bleeding, cancer history, cardiovascular and clotting history, liver disease, migraine, and current medications.

Treatment should be revisited periodically. New bleeding, chest pain, sudden shortness of breath, one-sided weakness, a severe new headache, or other urgent symptoms need prompt medical assessment rather than a routine telehealth message.

• Use the lowest effective dose consistent with the goal
• Review symptom response and side effects
• Keep age-appropriate screening current
• Reassess route, dose, and continued need over time